Stock Events

Stock Events

Kelyniam Global 

$0.130000
7
+$0.01+8.33% Wednesday 20:00

Statistics

Day High
0.145
Day Low
0.13
52W High
0.3
52W Low
0.07
Volume
16,200
Avg. Volume
4,639
Mkt Cap
6.52M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
0
0.01
0.01
Expected EPS
N/A
Actual EPS
0.0087

Financials

-4.55%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.05MRevenue
-139,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Stryker
SYK
Mkt Cap126.84B
Stryker Corporation is a leading medical technology company that offers a wide range of medical devices, including cranial and spinal implants, directly competing with Kelyniam Global's custom cranial implants.
Medtronic
MDT
Mkt Cap116.77B
Medtronic plc specializes in medical devices for various conditions, including neurosurgery products that compete with Kelyniam's offerings.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare products, including surgical solutions for the skull, competing in the same space as Kelyniam.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its subsidiary DePuy Synthes, offers neurosurgical and craniofacial products, making it a competitor in the cranial implant market.
Globus Medical
GMED
Mkt Cap11.14B
Globus Medical, Inc. is a musculoskeletal solutions company that offers innovative spinal and cranial surgery solutions, competing with Kelyniam's custom implants.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, Inc. designs, manufactures, and markets robotic products for surgery, indirectly competing by offering alternative surgical solutions.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including neurointerventional devices.
Align Technology
ALGN
Mkt Cap11.19B
Align Technology, Inc. focuses on dental products but its technology and approach to custom medical devices can be seen as indirectly competing with Kelyniam's custom implant solutions.
Smith & Nephew
SNN
Mkt Cap12.12B
Smith & Nephew plc offers advanced medical devices in orthopedics, including some products that could be used in cranial and neuro surgeries, making it a competitor.

About

Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced medical-grade polymers. Additionally, Kelyniam develops, produces, and supplies specific cranial and craniofacial fixation screws, crucial for the reconstruction of skull and facial structures. Its clientele encompasses health systems, hospitals, sales representatives, surgeons, insurance providers (payors), and individual patients. Established in 2005, the company was originally named Ketner Global Investments, Inc., rebranding to Kelyniam Global, Inc. in December 2007. Kelyniam Global is based in Collinsville, Connecticut.
Show more...
CEO
Ross Bjella
Employees
9
Country
United States
ISIN
US4883591004

Listings

OTC Link
US
KLYG

0 Comments

Share your thoughts

FAQ

What is Kelyniam Global stock price today?▼
The current price of KLYG is $0.13 USD — it has increased by +8.33% in the past 24 hours. Watch Kelyniam Global stock price performance more closely on the chart.
What is Kelyniam Global stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Kelyniam Global stocks are traded under the ticker KLYG.
Is Kelyniam Global stock price growing?▼
KLYG stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Kelyniam Global has showed a +85.71% increase.
What is Kelyniam Global market cap?▼
Today Kelyniam Global has the market capitalization of 6.52M
What were Kelyniam Global earnings last quarter?▼
KLYG earnings for the last quarter are 0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kelyniam Global revenue for the last year?▼
Kelyniam Global revenue for the last year amounts to 3.05M USD.
What is Kelyniam Global net income for the last year?▼
KLYG net income for the last year is -139,000 USD.
How many employees does Kelyniam Global have?▼
As of September 04, 2026, the company has 9 employees.
In which sector is Kelyniam Global located?▼
Kelyniam Global operates in the Health & Wellness sector.
When did Kelyniam Global complete a stock split?▼
Kelyniam Global has not had any recent stock splits.
Where is Kelyniam Global headquartered?▼
Kelyniam Global is headquartered in Canton, United States.